Fulgent Genetics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio6.285.915.90
Forward P/E13.807.11
P/S Ratio1.992.961.453.023.00
P/B Ratio0.500.760.712.572.22
Price/Tangible Book0.580.880.932.802.22
Price/FCF178.633.835.8311.99
Price/OCF26.8231.733.555.578.99
PEG Ratio0.200.200.200.200.20
Enterprise Value Ratios
EV/Revenue0.100.042.182.76
EV/EBITDA0.123.143.97
EV/EBIT0.143.194.01
EV/FCF5.910.114.2011.03
Profitability & Returns
Return on Equity (ROE)-0.04%-0.15%0.12%0.58%0.66%
Return on Assets (ROA)-0.04%-0.04%0.09%0.43%0.46%
Return on Invested Capital (ROIC)-0.09%-0.10%0.18%0.97%1.26%
Return on Capital Employed (ROCE)-0.06%-0.07%0.14%0.58%0.51%
Leverage & Solvency Ratios
Debt/Equity0.010.010.030.030.03
Debt/EBITDA0.170.040.05
Debt/FCF3.450.160.060.15
Liquidity Ratios
Current Ratio4.856.967.135.814.02
Quick Ratio4.606.606.835.643.87
Efficiency Ratios
Asset Turnover0.230.220.471.001.07
Yield & Distribution Ratios
Earnings Yield-0.08%-0.20%0.16%0.17%0.17%
FCF Yield-0.03%0.01%0.26%0.17%0.08%
Buyback Yield-0.02%0.04%0.00%-0.29%-0.29%